Skip to contentApplication 210976
- Type
- ANDA
- Sponsor
- WATSON LABS INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | PENICILLAMINE | PENICILLAMINE | CAPSULE;ORAL | 250MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0591-4171 | Penicillamine | Penicillamine | Actavis Pharma, Inc. | ANDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 59243 | ORIG | 2019-07-05 |